Back to Search
LINDSAY KILBURN, MD
MD
Pediatric Hematology & Oncology Physician
NPI: 1023215944Individual
Specialties, Licenses & Credentials
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
M6235(TX)
Research & Publications (14)
Plasma and cerebrospinal fluid pharmacokinetics of tasidotin (ILX-651) and its metabolites in non-human primates.
PMID 19043710·Cancer Chemother Pharmacol·2009
7-preclinical
Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma.
PMID 18952980·Neuro Oncol·2009
8-other
Examining the acute effects of cediranib (RECENTIN, AZD2171) treatment in tumor models: a dynamic contrast-enhanced MRI study using gadopentate.
PMID 18814988·Magn Reson Imaging·2009
7-preclinical
'Triple negative' breast cancer: a new area for phase III breast cancer clinical trials.
PMID 17977700·Clin Oncol (R Coll Radiol)·2008
8-other
Combining fulvestrant (Faslodex) with continued oestrogen suppression in endocrine-sensitive advanced breast cancer: the SoFEA trial.
PMID 18387790·Clin Oncol (R Coll Radiol)·2008
8-other
Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study.
PMID 17267326·Lancet Oncol·2007
4-observational
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.
PMID 17307102·Lancet·2007
4-observational
Relative potential for selection of quinolone-resistance-determining-region mutations in Streptococcus pneumoniae by gemifloxacin, gatifloxacin and moxifloxacin.
PMID 17024792·J Chemother·2006
8-other
AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer.
PMID 15899831·Cancer Res·2005
7-preclinical
Impact of the international term breech trial on clinical practice and concerns: a survey of centre collaborators.
PMID 12548320·J Obstet Gynaecol Can·2003
4-observational
Interspecies recombination contributes minimally to fluoroquinolone resistance in Streptococcus pneumoniae.
PMID 11502541·Antimicrob Agents Chemother·2001
8-other
A nosocomial outbreak of fluoroquinolone-resistant Streptococcus pneumoniae.
PMID 11462189·Clin Infect Dis·2001
8-other
Genetic locus for streptolysin S production by group A streptococcus.
PMID 10858242·Infect Immun·2000
8-other
Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance.
PMID 11036021·Antimicrob Agents Chemother·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6701 FANNIN ST
HOUSTON, TX 77030 - Phone
- (832) 822-4890
Quick Facts
- NPI
- 1023215944
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 14
Are you this provider?
Claim Your Profile